Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Obesity 5 Endometrial Neoplasms 4 Endometrial Hyperplasia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Overweight 1 Opioid-Related Disorders 1 Lymphoma, Follicular 1 Insulin Resistance 1 Hyperplasia 1 Diabetes Mellitus 1

Interventions

Ultrasonic Waves 1 Tirzepatide 1 Standard of Care 1 Olanzapine 1 Educational Status 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Opioid-Related Disorders × Tirzepatide × 90 days × Clear all

NCT06651177 2026-05-22

TAB

University of Cincinnati

Phase 2 Recruiting

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡